Learning Reward Uncertainty in the Basal Ganglia Tekijä Bogacz, R, Mikhael, J

Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Coh... Tekijä Griffiths, R, Gleeson, M, Mikhael, J, Danese, MD

Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma Tekijä Griffiths, R, Gleeson, M, Mikhael, J, Dreyling, M, Danese, MD

Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma. Tekijä Griffiths, R, Gleeson, M, Mikhael, J, Dreyling, M, Danese, MD

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma. Tekijä Griffiths, R, Mikhael, J, Gleeson, M, Danese, M, Dreyling, M

Health care utilization and mortality among elderly patients with myelodysplastic syndromes. Tekijä Lindquist, K, Danese, MD, Mikhael, J, Knopf, K, Griffiths, R

An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia. Tekijä Danese, MD, Griffiths, R, Gleeson, M, Satram-Hoang, S, Knopf, K, Mikhael, J, Reyes, C